STOCK TITAN

Esperion to Participate in Upcoming Virtual J.P. Morgan 40th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Esperion (NASDAQ: ESPR) announced that President and CEO Sheldon Koenig will present at the J.P. Morgan 40th Annual Healthcare Conference on January 13, 2022, at 10:30 a.m. ET. The presentation will include a live audio webcast available on the company's investor relations website, with replays archived for 90 days. Esperion focuses on lipid management, developing innovative medicines to lower cholesterol for patients underserved by existing solutions. More details can be found at www.esperion.com.

Positive
  • None.
Negative
  • None.

ANN ARBOR, Mich., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that President and Chief Executive Officer, Sheldon Koenig, will present at the upcoming virtual J.P. Morgan 40th Annual Healthcare Conference on Thursday, January 13, 2022 at 10:30 a.m. Eastern Time.

Event:J.P. Morgan 40th Annual Healthcare Conference
Date:Thursday, January 13, 2022
Format:Presentation and 1:1 Meetings
Time:10:30 a.m. ET

Live audio webcasts of these events can be accessed on the investor relations section of the Esperion website at www.esperion.com/investors-media/events-presentations/. Replays of the webcasts will be archived on the Company's website for 90 days following the events.

Esperion Therapeutics

Esperion is The Lipid Management Company. Our goal is lipid management for everybody, that’s why we work hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.

Investor Contact:
Kaitlyn Brosco
Esperion
corporateteam@esperion.com


FAQ

When is Esperion's presentation at the J.P. Morgan Healthcare Conference?

Esperion's presentation at the J.P. Morgan 40th Annual Healthcare Conference is scheduled for January 13, 2022, at 10:30 a.m. ET.

Who is presenting for Esperion at the J.P. Morgan Conference?

Sheldon Koenig, President and CEO of Esperion, will present at the conference.

Where can I watch the Esperion presentation live?

You can watch the live audio webcast of Esperion's presentation on their investor relations website.

How long will the replay of the Esperion presentation be available?

Replays of the presentation will be available for 90 days following the event.

What is Esperion's focus in the healthcare market?

Esperion focuses on lipid management, developing innovative medicines to lower cholesterol for patients with unmet needs.

Esperion Therapeutics, Inc.

NASDAQ:ESPR

ESPR Rankings

ESPR Latest News

ESPR Stock Data

389.34M
189.46M
0.5%
69.24%
18.03%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
ANN ARBOR